PE/Cyanine5.5 Anti-Human CD3 Antibody[OKT3]

PE/Cyanine5.5 Anti-Human CD3 Antibody[OKT3]

Introducing the PE/Cyanine5.5 Anti-Human CD3 Antibody [OKT3], a cutting-edge product designed to revolutionize immunological research and diagnostics. This antibody, meticulously developed by our team of experts, offers unparalleled specificity and sensitivity in detecting human CD3, a crucial marker for T-cell identification and activation.

The PE/Cyanine5.5 conjugate ensures optimal fluorescence emission, enabling precise and reliable flow cytometry analysis. With its exceptional brightness and minimal background noise, this antibody guarantees accurate and reproducible results, facilitating comprehensive investigations into T-cell biology and immune responses.

Our PE/Cyanine5.5 Anti-Human CD3 Antibody [OKT3] exhibits exceptional binding affinity to CD3, ensuring robust and consistent staining across various sample types. Its high specificity eliminates cross-reactivity, allowing for precise discrimination of CD3-positive cells from other cellular populations.

This antibody is meticulously manufactured under stringent quality control measures, ensuring batch-to-batch consistency and reliability. Its exceptional stability and long shelf life make it an ideal choice for routine laboratory use and large-scale experiments.

The PE/Cyanine5.5 Anti-Human CD3 Antibody [OKT3] is supplied in a convenient and user-friendly format, enabling seamless integration into existing laboratory protocols. Its compatibility with a wide range of sample types, including peripheral blood, lymphoid tissues, and cell lines, further enhances its versatility and applicability.

In summary, the PE/Cyanine5.5 Anti-Human CD3 Antibody [OKT3] represents a breakthrough in immunological research, offering researchers and clinicians an invaluable tool for unraveling the complexities of T-cell biology. With its exceptional performance, reliability, and ease of use, this antibody is poised to revolutionize the field and drive advancements in immunotherapy, diagnostics, and beyond.